Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Healthcare Services Roundup through April 2018
It’s been quite a year for healthcare deals in general, with nearly 600 announced transactions in the first four months. That’s 7% more than there were announced in the first four months of 2017. Dollar volume has soared, too. In 2018, $141.8 billion has already been committed to fund the 588 transactions. Thanks to some mega-billion-dollar deals in 2018, the total is 30% greater than the nearly $109 billion spent in the same period of 2017. Collectively, the Services sectors are booming, which isn’t always the case. Services deals made up 63% of all deals in the first four months of 2018, and 57% of the disclosed dollars, now at $81.3 billion. The Technology sectors... Read More »
Eli Lilly Doubles Down on Immuno-Oncology
ARMO BioSciences (NASDAQ: ARMO) is a late-stage immuno-oncology company that develops a pipeline of novel, proprietary product candidates designed to activate the immune system of cancer patients to recognize and eradicate tumors. On a trailing 12-month basis, it generated a net loss of $42.4 million. Eli Lilly and Company (NYSE: LLY) overlooked the loss as it eyed the real prize–the addition of pegilodecakin, a PEGylated IL-10, which has demonstrated clinical benefits as a single agent, and in combination with both chemotherapy and checkpoint inhibitor therapy, across several tumor types. Pegilodecakin is currently being studied in a Phase 3 clinical trial in pancreatic cancer, and... Read More »Takeda Takes on Shire for $81.5 Billion
Big Pharma deals are back, more than ever. After six weeks of offers, refusals, talks and more, Japanese drug giant Takeda Pharmaceutical Company Limited (OTCQB: TKPYY) reached an agreement to acquire Shire plc (NASDAQ: SHPG) for $81.5 billion, including assumed debt of $19.54 billion. It’s the largest healthcare deal announced ever, unless you count Pfizer’s (NYSE: PFE) hostile stalking of AstraZeneca (NYSE: AZN) through much of 2014, with bids reported to be around $118 billion. And we don’t. Looking back over past pharmaceutical deals (that closed), this takes the record from Pfizer, which announced its acquisition of Wyeth, Inc. for approximately $78.5 billion, including $10.5 billion... Read More »
Fred’s Exits Specialty Pharmacy, CVS Gains
Fred’s Inc. (NASDAQ: FRED) has had second thoughts about the specialty pharmacy business. Three years ago, in March 2015, the retailer acquired Reeves-Sain Drug Store, Inc., a retail pharmacy with a single location in Murfreesboro, Tennessee. Included in the $66 million deal was EntrustRx Specialty Pharmacy, a direct-to-consumer operation with three locations in Mississippi and Tennessee. EnTrustRx was licensed in all 50 states, and dispenses specialty pharmaceuticals to treat complex conditions and diseases that require ongoing support for extensive periods of time. Its main therapy lines include hepatitis C, oncology, growth hormones, multiple sclerosis and rheumatology. In the... Read More »
Health Care M&A Weekly Deals, The Week Ending May 4, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Spectrum Pharmaceuticals, Inc. Exclusive license to methods of use of poziotinib N/A Janssen Biotech, Inc. BeneVir Biopharm, Inc. N/A Vascugen Inc. Exclusive license to blood vessel formation technology... Read More »
SCIO Health Analytics Sold for $240 Million
ExlService Holdings, Inc. (NASDAQ: EXLS), a leading operations management and analytics company, deepened its investment in healthcare analytics with its announced $240 million acquisition of SCIOInspire Holdings, Inc. (SCIO), a West Hartford, Connecticut-based leading healthcare analytics solution and services company (dba SCIO Health Analytics). SCIO helps its clients identify and resolve underlying issues that lead to excessive spending and sub-optimal health outcomes. Together, the companies will provide a broader range of solutions in payment integrity, care management and customer engagement. TripleTree, LLC acted as the exclusive financial advisor to SCIO for this... Read More »
April 2018 Healthcare Deals Explode
Boom! That was April 2018’s M&A results breaking the sound barrier. With 167 transactions, the monthly deal total (almost) blew away the record for deals in a single month. The current record is now January 2017, with 178 transactions. With time, as more deals come to light, April 2018 may be the new champion. Deal volume was 21% higher than the 138 transactions reported in March 2018, and up 55% compared with April 2017’s 108 transactions. The Long-Term Care sector was a major force behind the surge in deal volume. A record 46 deals were reported, representing a 92% increase over March’s anemic 24 deals, and a 130% gain over the 20 deals reported a year earlier.... Read More »
Fresenius Sells Sound Inpatient Physicians for $2.15 Billion
What began in 2014 as a grand round of acquisitions of physician medical groups became a multi-billion-dollar exit four years later. Fresenius Medical Care (NYSE: FMS), the world’s largest provider of dialysis products and services, took “an important strategic step to sharpen its U.S. Care Coordination profile” and sell its controlling interest in Sound Inpatient Physicians Holdings, LLC for $2.15 billion. The buyers are led by Summit Partners, a Boston-based private equity firm. Back in June 2014, Fresenius acquired Sound Physicians, as it was called, for $600 million. The group was comprised of more than 1,000 physicians in more than 100 hospitals. The acquisition was... Read More »
SwipeSense Acquires iScrub Lite
Just in time for World Hand Hygiene Day (Saturday, May 5, 2018), SwipeSense announced its acquisition of iScrub Lite, the leading mobile application for hand hygiene observation. Yes, that’s real thing. iScrub Lite was conceive and developed by the Computational Epidemiology Research Group at the University of Iowa. It was launched to simplify the error-prone process of recording hand hygiene observations and sharing the results with healthcare professionals. Dr. Philip Polgreen, associate professor of internal medicine and epidemiology at the University of Iowa, said his team created iScrub to serve the infection control community. “However, the costs of updating the service have... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
